Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015

Cancer genomics and pancreatic cancer

Prof Andrew Biankin - University of Glasgow, Glasgow, UK
Cancer genomics and pancreatic cancer ( Prof Andrew Biankin - University of Glasgow, Glasgow, UK )
11 Nov 2014

ePOSSOM: New free online education for postgraduate surgeons

Richard Bamford - Severn Postgraduate School of Surgery, Bristol, UK
ePOSSOM: New free online education for postgraduate surgeons ( Richard Bamford - Severn Postgraduate School of Surgery, Bristol, UK )
10 Oct 2014

Growing tissue stem cells into organoids and tumeroids: Predictive assay development

Prof Hans Clevers - Hubrecht Institute, Utrecht, The Netherlands
Growing tissue stem cells into organoids and tumeroids: Predictive assay development ( Prof Hans Clevers - Hubrecht Institute, Utrecht, The Netherlands )
26 Jun 2014

Personalised cancer medicine using the human protein atlas and affibodies

Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden
Personalised cancer medicine using the human protein atlas and affibodies ( Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden )
26 Jun 2014

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

Prof Peter Hillmen - St James’ University Hospital, Leeds, UK
Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows ( Prof Peter Hillmen - St James’ University  Hospital, Leeds, UK )
19 Jun 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France
Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )
1 May 2014